Epsilon M&A Deal Report - ELITech Group
Transaction Multiples for the Valuation of Private Companies
Bruker / ELITech Group
No EMAT :
121565
Announced Date :
26/12/2023
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Bruker
Target :
ELITech Group
Country :
France
Sector of activity :
- Health, Pharmaceuticals & Biotechnology > Biotechnology
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
ELITechGroup is an integrated in-vitro diagnostics (IVD) company which develops and commercializes proprietary molecular diagnostic (MDx) systems and assays, as well as niche biomedical systems and...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 45
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 39
| Date | Acquirer | Target | Country | Multiples | See details |
| 31/07/2021 | Private Group led by Apposite Capital | I2a (Intelligence Articielle Application) | France | ** | 121527 |
| 24/02/2023 | Private Group led by EMZ Partners | Fovéa | France | * | 121433 |
Source: Epsilon Research / EMAT
